Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00029120|
Recruitment Status : Completed
First Posted : January 7, 2002
Last Update Posted : July 2, 2017
The purpose of this study is to examine how a part of the brain called the hippocampus contributes to memory changes that occur with aging and Alzheimer's disease (AD).
Memory problems are the most important early symptoms of AD. The hippocampal region of the brain may be responsible for many age- and AD-related memory disorders. This study will use magnetic resonance imaging (MRI) scans to examine the structure, chemical composition, and function of the hippocampus in participants with AD, participants with mild memory problems, participants who are healthy but are at risk for AD, and healthy volunteers.
Participants in this study will undergo MRI scans of the brain. During the MRI, participants will perform memory tests to demonstrate hippocampal functioning.
|Condition or disease|
|Alzheimer Disease Dementia Memory Disorder Healthy|
|Study Type :||Observational|
|Estimated Enrollment :||450 participants|
|Official Title:||MRI Contrast Imaging in the Evaluation and Follow-up of Patients With Memory Disorder and Healthy Controls|
|Study Start Date :||December 18, 2001|
|Estimated Study Completion Date :||April 21, 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00029120
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|